The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer.  

Devised with three crucial and bold intentions, this meeting will enable you too:

• Overcome the key biological obstacles constraining truly successful prostate cancer therapies
• Discuss novel, cutting edge targeted therapies for prostate cancer
• Bring together key stockholders within the prostate cancer drug development field with the common aim of bringing-to-market safe, efficient treatments to patients-in-need